首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2379篇
  免费   214篇
  国内免费   58篇
耳鼻咽喉   18篇
儿科学   106篇
妇产科学   18篇
基础医学   324篇
口腔科学   45篇
临床医学   337篇
内科学   435篇
皮肤病学   71篇
神经病学   130篇
特种医学   348篇
外科学   212篇
综合类   88篇
一般理论   1篇
预防医学   165篇
眼科学   27篇
药学   185篇
中国医学   2篇
肿瘤学   139篇
  2022年   17篇
  2021年   45篇
  2020年   24篇
  2019年   32篇
  2018年   49篇
  2017年   28篇
  2016年   21篇
  2015年   37篇
  2014年   47篇
  2013年   91篇
  2012年   86篇
  2011年   64篇
  2010年   80篇
  2009年   96篇
  2008年   79篇
  2007年   116篇
  2006年   71篇
  2005年   81篇
  2004年   71篇
  2003年   63篇
  2002年   65篇
  2001年   60篇
  2000年   62篇
  1999年   52篇
  1998年   82篇
  1997年   93篇
  1996年   115篇
  1995年   74篇
  1994年   67篇
  1993年   60篇
  1992年   50篇
  1991年   48篇
  1990年   51篇
  1989年   65篇
  1988年   62篇
  1987年   55篇
  1986年   69篇
  1985年   65篇
  1984年   25篇
  1983年   20篇
  1982年   22篇
  1981年   20篇
  1980年   21篇
  1979年   29篇
  1978年   23篇
  1977年   22篇
  1976年   23篇
  1975年   17篇
  1973年   7篇
  1972年   8篇
排序方式: 共有2651条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.

Background

Pediatric surgical randomized clinical trials (RCTs) are labor-intensive and costly. This systematic review investigated patient accrual and estimates of study duration in RCTs by interrogating enrollment and registration practices.

Methods

We performed a peer-review search of multiple databases from 2000 to 2016 evaluating RCTs salient to the field with inclusion mandated that a self-identified pediatric surgeon be listed as an author. Trial registries were also searched. RCTs were appraised, and predictors of success were evaluated using multivariate logistic regression, with success defined as achievement of recruitment objectives.

Results

After screening, 137 RCTs were analyzed. Mean Jadad score was 1.80 (median = 2). CONSORT scores ranged between 17% and 97% (median = 58%). Sixty-seven studies described sample-size determination, 49 reported projected enrollment, and 26 were successful. Among 26 registered RCTs, 15 disclosed their expected completion date, which was achieved by 8. On average, protocols underwent 3.42 iterations. 9% of trials were terminated before completion, most commonly owing to poor recruitment. Trial registration and urgent cases significantly predicted success on multivariable analysis (p < 0.05).

Conclusion

Overall quality of reporting in pediatric surgical trials is poor. Sample-size calculation and patient accrual are frequently poorly performed or underestimated, resulting in trial overrun and/or premature termination. These data may help inform subsequent study design and facilitate successful completion.

Level of Evidence

Level III—Systematic Review and Observational (Case–Control) Analysis.  相似文献   
996.
Résumé  Les douleurs chroniques, d’origine inflammatoire ou neuropathique, s’accompagnent de modifications cellulaires responsables d’une sensibilisation persistante et handicapante. L’étude de ces phénomènes de plasticité nécessite de disposer de modèles animaux fiables. De nombreux modèles existent qui ne font chacun que reproduire certains des sympt?mes douloureux. Leur choix dépend donc des pathologies étudiées. L’apparition de modèles génétiquement modifiés avait fait na?tre de grands espoirs mais les phénotypes apparents de ces animaux se révèlent souvent contradictoires, et difficiles à interpréter. Une composante importante de la plasticité associée à la sensibilisation douloureuse concerne le contenu neurochimique des cellules localisées dans les ganglions rachidiens ou la corne dorsale de la moelle épinière. Cette plasticité neurochimique est illustrée par les variations d’expression de deux neuropeptides, la galanine et la cholécystokinine, ainsi que de leurs récepteurs. Au niveau du premier relais sensoriel, la galanine exercerait un effet essentiellement antinociceptif, à fortes doses, en conditions neuropathiques via son récepteur R1. A l’inverse, la cholécystokinine jouerait un r?le pronociceptif dans les neurones spinaux en s’opposant à l’action des opiacés endogènes via le récepteur CCK2. La connaissance des mécanismes d’action des messagers est nécessaire à l’élaboration de traitements thérapeutiques innovants. Parmi les messagers chimiques impliqués dans la transmission douloureuse, les neuropeptides représentent une cible thérapeutique de choix en raison de leur caractère modulateur et de leur forte plasticité d’expression. Néanmoins, le développement d’analgésiques dérivés d’agonistes ou d’antagonistes de ces peptides nécessite encore de parfaire la connaissance de leurs mécanismes d’action et de leurs interactions et ces progrès requièrent l’utilisation de modèles animaux pertinents.
Summary  Chronic pain is associated with plastic changes responsible from a persitent sensitization in the spinal cords. The studies of these changes have benefit substantially from the development of experimental animal models. If genetically modified animals have carried a lot of new perspective and hopes, their practical use is difficult due to the important phenotypic variability seen amongst them. However, an important aspect of central sensitization is linked with the changes of expression of neuropeptide such as galanin and cholecystokinin and their receptors. In the dorsal horn, galanin has analgesic effects trough its receptor R1. Conversly, cholecystokinin induces pain via an inhibition of endogenous opio?ds through the CCK2 receptor. Future prospect in analgesic drugs requires a good knowledge about the biochemical cascades involved in the transmission of pain. Amongst these, neuropeptides are good candidate targets because they have a strong analgesic potential, and their expression is highly modulated in persistent pain syndromes. The development of this line of research is still pending on the use of appropriate animal models as well as a better knowledge about their mechanisms.
  相似文献   
997.

Background

To examine the epidemiology, treatments, and outcomes of acute symptomatic non-atherosclerotic mesenteric vascular disease.

Methods

Subjects were reviewed over a six year period. Categories included embolism (EM), dissection (DI), and aneurysm (AN). Presentation, demographics, treatment and outcomes were compared.

Results

46 patients were identified (EM:20, AN:15, DI:11). Age at presentation differed (EM: 66.3, AN 62.4, DI 54.6, p?<?.05). EM more likely affected the superior mesenteric artery (EM80%, AN20%, DI45%, p?=?.002), DI hepatic artery (EM20%, AN13%, DI55%, p?<?.05), and AN mesenteric branches (EM5%, AN47%, DI0%; p?=?.001). EM more likely had history of arrhythmia (EM40%, AN7%, DI0%, p,0.05) and diarrhea (EM30%, AN7%, DI0%, p?<?.05). Treatment was most often surgical in EM (EM85%, AN33%, DI9%, p?<?.001), endovascular in AN (EM5%, AN40%, DI 9%, p?<?.02), and conservative in DI (EM15%, AN 33%, DI82%, p?<?.05). In hospital mortality was infrequent (EM10%, AN7%, DI0%, p?=?ns). Mean hospital length of stay differed by mechanism (EM13.6days, AN9.2, DI2.3, p?=?.005). Median follow up was 61 months. Survival at 1, 3 and 5 years for emboli was 75%, 70% and 59%, for aneurysms 93%, 86%, and 77%, and for dissections 100% at all time points (p?=?.043 log rank).

Conclusions

Patients with EM, AN, and DI differ in age, anatomic distribution and method of treatment. The etiology significantly affects long term survival.  相似文献   
998.
In vitro antioxidant properties of calcium dobesilate   总被引:4,自引:0,他引:4  
Summary— Calcium dobesilate, a vascular protective agent, was tested in vitro for its scavenging action against oxygen free radicals. Calcium dobesilate was as potent as rutin to scavenge hydroxyl radicals (ICW = 1.1 vs 0.7 μM, respectively). It was also able to scavenge superoxide radicals, but with 23 times less potency than rutin (IC50 = 682 vs 30 μM, respectively). Calcium dobesilate significantly reduced platelet activating factor (PAF)-induced chemiluminescence in human PMN cells and lipid peroxidation by oxygen free radicals in human erythrocyte membranes, although these actions required calcium dobesilate concentrations ≥ 50 μM. Finally, in cultured bovine aortic endothelial cells, magnesium dobesilate reduced the increase in cytosolic free calcium induced by hydrogen peroxide and inhibited phenazine methosulfate-induced cell potassium loss. In conclusion, calcium dobesilate was effective in scavenging hydroxyl radicals in vitro, at therapeutically relevant concentrations. Conversely, higher concentrations of the compound were required to scavenge superoxide radicals or to protect the cells against the deleterious effects of intracellular reactive oxygen species. Further studies in vivo are required to determine if these antioxidant properties of calcium dobesilate can play a role in its vascular protective mechanisms.  相似文献   
999.
自制复合抗肿瘤珊瑚羟基磷灰石人工骨体外抗肿瘤实验   总被引:1,自引:3,他引:1  
目的:评价自制复合抗肿瘤珊瑚羟基磷灰石人工骨体外抗肿瘤活性。方法:实验于2006-01/12在解放军广州军区广州总医院骨科及南方医科大学基础医学院细胞生物学教研室实验室进行。①将南海澄黄海珊瑚礁块制成的珊瑚碳酸钙通过水热反应转变成珊瑚羟基磷灰石人工骨后,再通过真空冷冻干燥等处理将顺铂载入形成复合抗肿瘤珊瑚羟基磷灰石人工骨,将复合人工骨一部分切开后行电镜扫描及能谱分析,以了解顺铂在人工骨孔隙中的分布及比例。②另精确称取复合人工骨1g浸入避光模拟体液50mL中,37℃,30r/min恒温振荡器中浸泡后,取得不同时间浸提液各10mL,将浸提液过滤除菌分装后再真空冷冻干燥制成粉剂低温保存。③以乳腺癌骨转移原代培养细胞(标本取自广州军区广州总医院手术切除标本)、高转移性肺癌SPCA-1细胞株及前列腺癌骨转移pc-3细胞株(购自中国生命科学院上海细胞所)为实验对象,利用MTT法分别检测对照组(单纯羟基磷灰石浸提液)、复合人工骨2,4,6及8周浸提液的体外抑制肿瘤细胞作用(计算肿瘤细胞的抑制率)。结果:①复合人工骨孔隙内顺铂分布均匀,能谱分析示复合顺铂占人工骨的体质量的10.05%。②复合人工骨2,4,6及8周浸提液体外对乳腺癌细胞的抑制率分别为71.83%,68.34%,63.74%及62.35%;对肺癌细胞的抑制率分别为81.59%,80.14%、74.81%及62.89%;对前列腺癌细胞的抑制率分别为85.04%,84.34%,65.66%及29.92%。除8周浸提液对前列腺癌的抑制率为29.92%为低度敏感外,复合人工骨8周内的浸提液在体外对肿瘤细胞的抑制率均>50%,为高度敏感。结论:自制顺铂珊瑚羟基磷灰石复合人工骨具有良好的缓释功能,其缓释液在8周内可抑制及杀伤肿瘤细胞。  相似文献   
1000.
Nucleic acid hybridization in the diagnosis of viral infections   总被引:1,自引:0,他引:1  
Recombinant DNA technology, including molecular cloning and nucleic acid hybridization, is now being applied to problems in clinical virology. Although viral isolation in cell culture remains the most sensitive and specific diagnostic test for many viruses, for some viruses, isolation in cell culture is lengthy or difficult or has not yet been achieved. Utilization of hybridization techniques has already resulted in important new information concerning the pathogenesis of a number of viruses, such as Epstein-Barr virus, hepatitis B virus, and human papillomavirus. In addition, time to diagnosis for viruses such as cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus can be significantly shortened to 36 to 48 hours, a great improvement over standard isolation with obvious importance for patient management. Hybridization techniques have also been applied to screening of antiviral agents. Although results of studies to date have been encouraging, significant problems remain to be solved before these techniques can be applied in a routine diagnostic laboratory. First, more sensitive assays must be developed. One approach is the generation of probes with higher specific activities. Synthesis of single-stranded probes using recombinant M13 bacteriophage as a template results in probes of higher specific activities that also cannot re-anneal to themselves because they are not complementary. Thus, more probe is available to anneal to sample DNA. Synthesis of cRNA probes that form more stable hybrids with DNA is another approach that is receiving attention. A second problem is reagent safety and stability. The most sensitive and commonly used label in the studies reviewed in this article has been 32P. With its half-life of 2 weeks, potential hazards to personnel, and disposal problems, it is probably not suitable for clinical laboratories. A major step in the development of nonradioactive, stable probes has been synthesis of biotinylated nucleotide analogues that can be efficiently incorporated into DNA or RNA. Biotinylated probes are stable for 1 to 2 years at -20 degrees C, and their use obviates the need for autoradiography, thus shortening reaction times. In addition, very high concentrations of probes can be used without the background problems encountered with radiolabels. To date, biotinylated probes have been significantly less sensitive than those labeled with 32P, but continued efforts to improve sensitivity have yielded promising results.(ABSTRACT TRUNCATED AT 400 WORDS)  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号